Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CTDSPL2 pseudogene 2 (CTDSPL2P2) is classified as a pseudogene in the human genome and does not encode a functional protein[6][7]. Pseudogenes are segments of DNA that resemble known genes but are typically nonfunctional due to mutations such as frameshifts or premature stop codons. CTDSPL2P2 is related in sequence to the functional gene CTDSPL2, which encodes a protein with RNA polymerase II CTD heptapeptide repeat phosphatase activity involved in the regulation of transcription by RNA polymerase II[1][4]. However, as a pseudogene, CTDSPL2P2 lacks documented biological function, molecular activity, or clinical relevance[6][7]. There are no approved drugs, disease associations, or biomarker roles associated with CTDSPL2P2, and it is not considered a drug discovery or therapeutic target. Additional context: - The reference gene, CTDSPL2, is a catalytic phosphatase involved in transcriptional regulation, but CTDSPL2P2 is not known to encode a similar active product[1][4][6]. - Pseudogenes like CTDSPL2P2 are important in evolutionary biology and genomics, sometimes modulating expression of their functional counterparts via non-coding RNA mechanisms, but there is no specific evidence for such a function for CTDSPL2P2[3]. Summary: CTDSPL2P2 is a pseudogene, not a therapeutic or biologically active target, and should not be used or referenced as a target for drug development or biomarker purposes[6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CTDSPL2 pseudogene 2 (CTDSPL2P2).